Literature DB >> 20399978

Anthrax infection in drug users.

Malcolm G Booth, John Hood, Timothy J G Brooks, Andrew Hart.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20399978     DOI： 10.1016/S0140-6736(10)60573-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

Review 1.  Armies of pestilence: CNS infections as potential weapons of mass destruction.

Authors:  B L Hart; L Ketai
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-04       Impact factor: 3.825

2.  Mouse monoclonal antibodies to anthrax edema factor protect against infection.

Authors:  Clinton E Leysath; Kuang-Hua Chen; Mahtab Moayeri; Devorah Crown; Rasem Fattah; Zhaochun Chen; Suman R Das; Robert H Purcell; Stephen H Leppla
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

Review 3.  Anthrax infection.

Authors:  Daniel A Sweeney; Caitlin W Hicks; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

4.  Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model.

Authors:  Caitlin W Hicks; Yan Li; Shu Okugawa; Steven B Solomon; Mahtab Moayeri; Stephen H Leppla; Ajana Mohanty; G Mani Subramanian; Thi S Mignone; Yvonne Fitz; Xizhong Cui; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-07       Impact factor: 4.733

5.  Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines.

Authors:  Amisha V Barochia; Xizhong Cui; Junfeng Sun; Yan Li; Steven B Solomon; Thi-Sau Migone; G Mani Subramanian; Sally D Bolmer; Peter Q Eichacker
Journal:  J Infect Dis       Date:  2012-01-05       Impact factor: 5.226

Review 6.  An overview of anthrax infection including the recently identified form of disease in injection drug users.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2012-04-24       Impact factor: 17.440

7.  Pediatric anthrax clinical management.

Authors:  John S Bradley; Georgina Peacock; Steven E Krug; William A Bower; Amanda C Cohn; Dana Meaney-Delman; Andrew T Pavia
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

8.  B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

Authors:  Yan Li; Xizhong Cui; Steven B Solomon; Kenneth Remy; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

9.  Shock and lethality with anthrax edema toxin in rats are associated with reduced arterial responsiveness to phenylephrine and are reversed with adefovir.

Authors:  Dante A Suffredini; Yan Li; Wanying Xu; Mahtab Moayeri; Stephen Leppla; Yvonne Fitz; Xizhong Cui; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-09-08       Impact factor: 4.733

10.  Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.

Authors:  Alexander N Wein; Brian N Williams; Shihui Liu; Boris Ermolinsky; Daniele Provenzano; Ruben Abagyan; Andrew Orry; Stephen H Leppla; Michael Peredelchuk
Journal:  J Med Chem       Date:  2012-09-18       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.